Ldio 1 M 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 histamine receptors, thereby reducing symptoms of allergic reactions including sneezing, nasal congestion, itching, and rhinorrhea. Montelukast, a leukotriene receptor antagonist, blocks leukotriene D4 at the cysteinyl leukotriene receptor, mitigating airway inflammation and bronchoconstriction commonly associated with asthma and allergic rhinitis. The combined action of these agents provides enhanced symptomatic relief by targeting multiple pathways involved in allergic responses. Ldio 1 M is typically administered once daily, with or without food, as directed by a healthcare professional. It is well-tolerated, though patients should be monitored for potential adverse effects such as headache, fatigue, gastrointestinal disturbances, or neuropsychiatric symptoms. Caution is advised in patients with hepatic impairment or a history of hypersensitivity to either component. This combination therapy offers an effective approach for patients inadequately controlled with monotherapy, improving quality of life by alleviating persistent allergic symptoms. Always consult a healthcare provider before initiating treatment.